The EPS projection of Xilinx, Inc. (NASDAQ:XLNX) for quarter ended 2016-09-30 is $0.54. Last week, the EPS forecast was $0.54 against target of $0.54, a month earlier. Two months ago, this estimate was $0.54 versus forecast of $0.54 three months earlier, implying a deviation of 0%.
Xilinx, Inc. (NASDAQ:XLNX) stated that 18 days ago, its stock price was positively revised 2 times while negative revisions were 7.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 0, and 1, correspondingly.
EPS estimate downgrade for Xilinx, Inc. (NASDAQ:XLNX) in the preceding 30, 120, 60 and 90 days were 0, 9, 2, and 9, correspondingly.
Xilinx, Inc. (NASDAQ:XLNX) EPS target for the quarter closed 4 was $0.54, based on 12 recommendations. As reported on 2016-04-27 the EPS was $0.54. The change was $0.02, implying a percentage deviation of 3.85%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
Xilinx, Inc. (NASDAQ:XLNX) yearly sales prediction for the fiscal 2018 stands at $644.944 and the median estimate is at $650. Almost 5 analysts issued sales target.
Highest sales target is $670 while the lowest target is $611 showing standard deviation of 21.597%.
As many as 5 analysts have sales targets revised upside while 5 reduced sales estimates, implying a deviation of 0%.
Last month, 5 revised sales number projection on upside while 5 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast. Xilinx, Inc. (NASDAQ:XLNX) announced that the deviation in forecast was 2.131%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...